Resonant Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Deficit) of Resonant LLC for the Period from January 1, 2013 to June 16, 2013, and Resonant Inc. for the Period from June 17, 2013 to December 31, 2013 and the Year Ended December 31, 2014

Condensed Consolidated Statements of Stockholders' Equity (Deficit) of Resonant LLC for the Period from January 1, 2013 to June 16, 2013, and Resonant Inc. for the Period from June 17, 2013 to December 31, 2013 and the Year Ended December 31, 2014 (USD $)	Resonant LLC Additional Paid-in Capital USD ($)	Resonant LLC Accumulated Deficit USD ($)	Resonant LLC Class B units	Resonant LLC Class C units USD ($)	Resonant LLC USD ($)	Common Stock USD ($)	Additional Paid-in Capital USD ($)	Accumulated Deficit USD ($)	Class B units	Class C units	Total USD ($)
Balance at Dec. 31, 2012				$ 46,351	$ 46,351
Balance (in units) at Dec. 31, 2012			500,000	300,000
Increase (Decrease) in Stockholders' Equity
Capital contributions				22,338	22,338
Sale of warrants	1,000				1,000
Net loss		(716,042)		(68,689)	(784,731)
Balance at Jun. 16, 2013	1,000	(716,042)			(715,042)
Balance (in units) at Jun. 16, 2013			500,000	300,000
Increase (Decrease) in Stockholders' Equity
Exchange of Class C member's units for subordinated note								(2,133,855)			(2,133,855)
Exchange of Class C member's units for subordinated note (in units)										(300,000)
Exchange of Class B members' units for common stock						1,000	(1,000)
Exchange of Class B members' units for common stock (in shares)						999,999			(500,000)
Sale of warrants							1,000				1,000
Net loss								(8,616,068)			(8,616,068)us-gaap_NetIncomeLoss
Balance at Dec. 31, 2013						1,000	1,000	(11,465,965)			(11,463,965)us-gaap_StockholdersEquity
Balance (in shares) at Dec. 31, 2013						999,999					999,999us-gaap_CommonStockSharesOutstanding
Increase (Decrease) in Stockholders' Equity
Sale of common stock in our initial public offering						3,105	18,626,895				18,630,000
Sale of common stock in our initial public offering (in shares)						3,105,000
Offering costs of our initial public offering							(2,388,026)				(2,388,026)
Reclassification of warrant liabilities							3,658,411				3,658,411
Conversion of convertible notes						2,787	9,397,213				9,400,000
Conversion of convertible notes (in shares)						2,787,667
Write -off of derivative liability upon conversion of notes payable							5,526,003				5,526,003
Vesting of restricted stock units						39					39
Vesting of restricted stock units (in shares)						39,318					(142,895)
Sale of warrants							1,000				1,000
Stock-based compensation							1,087,278				1,087,278
Tax withholding on net exercise of stock-based awards							29,591				29,591
Net loss								(9,731,210)			(9,731,210)us-gaap_NetIncomeLoss
Balance at Dec. 31, 2014						$ 6,931	$ 35,880,183	$ (21,197,175)			$ 14,689,939us-gaap_StockholdersEquity
Balance (in shares) at Dec. 31, 2014						6,931,984					6,931,984us-gaap_CommonStockSharesOutstanding